Michael Savona, MD

• Acute Myeloid Leukemia
• Chronic Myelomonocytic Leukemia

Dr. Savona is board certified in medical oncology and hematology, an elected fellow of the American College of Physicians, and a Leukemia and Lymphoma Society Clinical Scholar.

He is a physician scientist specializing in myeloid malignancies, and a leader in development of novel therapies for these patients. He has led development and approval of several novel therapies targeting the proteosome, BCL2 family proteins, PI3 kinase delta, the JAK/STAT pathway, and various epigenetic agents.